Aerosol Transmissible Diseases Safety Plans

New: SARS-CoV-2 and COVID-19 Guidance

IBC Guidance for BUAs involving SARS-CoV-2 and COVID-19.

Read More

Biosafety plans are required to minimize research laboratory employee exposure to Aerosol Transmitted Pathogens (ATP)

Each laboratory that works with any of the agents specified in Appendix D of the California Occupational Safety and Health Standards board Title 8, section 5199 must develop a biosafety plan. The Biosafety Plan must describe the procedures and measures to establish, implement and maintain an effective program to minimize research laboratory employee exposure to Aerosol Transmitted Pathogens – Laboratory (ATPs-L).

Download the template ATP-L Biosafety Plan
Please include the completed ATP-L biosafety plan with your new or renewal Biological Use Authorization Application.  If you have completed the ATP-L biosafety plan separately, please e-mail the completed plan to biosafety@ucdavis.edu.


Additional Guidance Regarding Your ATP Biosafety Plan

  • The Biosafety Plan must include the required information in sufficient detail to provide a useful training document for laboratory employees and students.
  • Completion and adoption of the biosafety plan does not substitute for obtaining a Biological Use Authorization (BUA) from the Institutional Biosafety Committee (IBC) that authorizes the possession, storage, transfer, and use of the biohazardous materials noted in a biosafety plan. 
  • Completion and annual update of a biosafety plan is a prerequisite for securing and maintaining IBC approval of your BUA.